Literature DB >> 12173127

Viral etiology of frequently recurring respiratory tract infections in children.

Johanna Nokso-Koivisto1, Anne Pitkäranta, Soile Blomqvist, Jukka Jokinen, Marjaana Kleemola, Aino Takala, Terhi Kilpi, Tapani Hovi.   

Abstract

The viral etiology of frequently recurring respiratory tract infection (FRRI) in children aged <2 years was studied. Altogether, 329 children were followed from 2 to 24 months of age in the Finnish Otitis Media Cohort Study. Children with FRRI were defined as having > or =9 episodes of upper respiratory tract infection (URI) and/or > or =4 episodes of acute otitis media during follow-up. Nasopharyngeal aspirates, middle ear fluid specimens, and serum samples were analyzed for 8 common respiratory viruses. Of 1358 URI episodes, 642 (47%) occurred in the 78 children with FRRI. At least 1 virus was associated with 62% of these episodes, whereas the corresponding figure for children without FRRIs was 54%. The frequency of different viruses was similar in both groups, but the relative proportion of rhinovirus infections was slightly higher among children with FRRI. In conclusion, a specific viral etiology does not explain the excess of URI episodes in children with FRRI.

Entities:  

Mesh:

Year:  2002        PMID: 12173127     DOI: 10.1086/341773

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  19 in total

1.  Detecting respiratory viruses in asymptomatic children.

Authors:  Sonali Advani; Arnab Sengupta; Michael Forman; Alexandra Valsamakis; Aaron M Milstone
Journal:  Pediatr Infect Dis J       Date:  2012-12       Impact factor: 2.129

2.  Duration of rhinovirus shedding in the upper respiratory tract in the first year of life.

Authors:  Michael J Loeffelholz; Rocio Trujillo; Richard B Pyles; Aaron L Miller; Pedro Alvarez-Fernandez; Dan L Pong; Tasnee Chonmaitree
Journal:  Pediatrics       Date:  2014-11-17       Impact factor: 7.124

3.  Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood.

Authors:  Teemu J Taipale; Kaisu Pienihäkkinen; Erika Isolauri; Jorma T Jokela; Eva M Söderling
Journal:  Pediatr Res       Date:  2015-09-15       Impact factor: 3.756

4.  Persistence of adenovirus nucleic acids in nasopharyngeal secretions: a diagnostic conundrum.

Authors:  Stella U Kalu; Michael Loeffelholz; Eric Beck; Janak A Patel; Krystal Revai; Jiang Fan; Kelly J Henrickson; Tasnee Chonmaitree
Journal:  Pediatr Infect Dis J       Date:  2010-08       Impact factor: 2.129

Review 5.  Epidemiology of human metapneumovirus.

Authors:  Jeffrey S Kahn
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

6.  Prevalence and clinical characterization of a newly identified human rhinovirus C species in children with acute respiratory tract infections.

Authors:  Yu Jin; Xin-Hui Yuan; Zhi-Ping Xie; Han-Chun Gao; Jing-Rong Song; Rong-Fang Zhang; Zi-Qian Xu; Li-Shu Zheng; Yun-De Hou; Zhao-Jun Duan
Journal:  J Clin Microbiol       Date:  2009-07-22       Impact factor: 5.948

7.  Serial viral infections in infants with recurrent respiratory illnesses.

Authors:  T Jartti; W-M Lee; T Pappas; M Evans; R F Lemanske; J E Gern
Journal:  Eur Respir J       Date:  2008-04-30       Impact factor: 16.671

8.  A relationship between acute respiratory illnesses and weather.

Authors:  A Costilla-Esquivel; F Corona-Villavicencio; J G Velasco-Castañón; C E Medina-DE LA Garza; R T Martínez-Villarreal; D E Cortes-Hernández; L E Ramírez-López; G González-Farías
Journal:  Epidemiol Infect       Date:  2013-08-02       Impact factor: 4.434

9.  The role of neonatal pulmonary morbidity in the longitudinal patterns of hospitalisation for respiratory infection during the first year of life.

Authors:  Kim S Betts; Ricardo J Soares Magalhães; Rosa Alati
Journal:  Epidemiol Infect       Date:  2018-05-08       Impact factor: 4.434

10.  Pediatric influenza prevention and control.

Authors:  Nicola Principi; Susanna Esposito
Journal:  Emerg Infect Dis       Date:  2004-04       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.